QSC Peptides
The most commonly asked question in testosterone ester research: what is the meaningful pharmacokinetic difference between Testosterone Enanthate and Testosterone Cypionate? Both are long-acting esters from QSC Peptides at 250mg/mL — but the ester chain length difference produces measurable t½ and release profile differences relevant to research protocol design.
Shop All QSC Steroids →| Property | Test Enanthate (Test E) | Test Cypionate (Test C) |
|---|---|---|
| Ester | Heptanoate (C7) | Cyclopentylpropionate (C8 equiv.) |
| Half-Life | ~7 days | ~8 days |
| Active Testosterone % | ~72% testosterone by weight | ~70% testosterone by weight |
| Oil Solubility | Good | Slightly higher (cyclopentyl) |
| Cmax Time | ~2–3 days post-injection | ~2–4 days post-injection |
| Injection Frequency | Every 7 days (research) | Every 7–10 days (research) |
| Geographic Preference | Global standard | USA clinical standard |
| QSC Peptides Concentration | 250mg/mL | 250mg/mL |
| QSC Peptides Price | $280 / 10-vial kit | $280 / 10-vial kit |
Testosterone Enanthate uses a heptanoate (7-carbon straight chain) ester. Testosterone Cypionate uses a cyclopentylpropionate (cyclopentyl ring + 3-carbon chain, equivalent to ~8 carbons in lipophilicity) ester. The cyclopentyl ring of Cypionate increases oil partition coefficient slightly, producing marginally slower depot release and a ~1-day longer half-life (~8 days vs ~7 days for Enanthate).
In practice, for most research purposes, the pharmacokinetic difference between Test E and Test C is small enough that protocol interchangeability is generally acceptable. However, for precise PK studies comparing ester release kinetics, both compounds from QSC Peptides provide a well-characterized ester pair within the same testosterone molecule.
QSC Peptides
QSC Peptides
QSC Peptides